IRCT20200127046282N33尚未招募1 期
Investigating the effectiveness of the combination therapy of CO2 fractional laser and conditioned medium derived from foreskin fibroblast cells in the treatment of burn scars compared to CO2 fractional laser alone : Phase 1 clinical trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 50 years（—）
- 性别
- All
入选标准
- •Patients with skin type 1-4
- •Patients with atrophic burn scars in more than one organ from 5 years ago to 3 months ago
排除标准
- •Age under 18 years
- •Patients who have received laser treatment in the last three months
- •Patients with active colloidal scar or active skin lesion at the injection site
- •Patients with coagulation and platelet disorders
- •Patients with a history of underlying disease such as diabetes and autoimmune connective tissue disease that affect wound healing
- •Patients with active viral infections
- •Patients with a history of anticoagulants
- •History of malignancy or receiving chemotherapy
- •Pregnancy and lactation
研究者
相似试验
尚未招募
3 期
Evaluation of the effectiveness of Berberis integerrima and Thyme essential oil in the treatment of acneAcne vulgaris.L70.0Acne vulgaIRCT20150721023282N21Esfahan University of Medical Sciences40
招募中
1 期
The effectiveness of PRP and Erbium laser in the treatment of dark circles around the eyesIRCT20080901001159N28Tehran University of Medical Sciences32
已完成
4 期
the effectiveness of Rocaltrol on treatment of albuminuria in pateint with diabetic nephropathy.diabetic nephropathy.Non-insulin-dependent diabetes mellitus with renal complicationsIRCT2015110624903N1Arak University of Medical Sciences132
已完成
2 期
Assessment of the efficacy of dressings in the treatment of cutaneous leishmaniasis due to Leishmania major: A randomized, single-blind controlled clinical trialCutaneous leishmaniasis.IRCT138707201166N2Tehran University of Medical Sciences210
已完成
不适用
A comparative study of the efficacy of combination therapy with oral omeprazole and low dose of systemic meglumine antimoniate versus the standard dose of systemic meglumine antimoniate in the treatment of cutaneous leishmaniasisCutaneous leishmaniasisSkin and Connective Tissue DiseasesISRCTN32701387Skin Diseases and Leishmaniasis Research Center (SDLRC) (Iran)150